Orion Infusions (DHA:ORIONINFU) Receivables Turnover : 1.76 (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Orion Infusions Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Orion Infusions's Revenue for the three months ended in Mar. 2024 was BDT208.9 Mil. Orion Infusions's average Accounts Receivable for the three months ended in Mar. 2024 was BDT118.7 Mil. Hence, Orion Infusions's Receivables Turnover for the three months ended in Mar. 2024 was 1.76.

Orion Infusions Receivables Turnover Historical Data

The historical data trend for Orion Infusions's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions Receivables Turnover Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Receivables Turnover

Get a 7-Day Free Trial

5.65

4.42

4.31

5.73

5.78

Orion Infusions Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															1.24	1.46	1.76	1.49	1.76

Competitive Comparison of Orion Infusions's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Infusions's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Orion Infusions's Receivables Turnover falls into.

Orion Infusions Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Orion Infusions's Receivables Turnover for the fiscal year that ended in Jun. 2023 is calculated as

	Receivables Turnover (A: Jun. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Jun. 2023 )	/ (	(Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )
=	810.153	/ (	(148.347	+	131.867)	/	2 )
=	810.153	/	140.107
=	5.78

Orion Infusions's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	208.926	/ (	(135.18	+	102.235)	/	2 )
=	208.926	/	118.7075
=	1.76

Orion Infusions (DHA:ORIONINFU) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Orion Infusions Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Orion Infusions's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines